Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)
CVS Health Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) increased by 5.4% to $2.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from $2.58B to $2.26B. Over 5 years (FY 2020 to FY 2025), Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) shows a downward trend with a -6.5% CAGR.
Analysis
How to read this metric
An increase indicates a strategic shift toward long-term asset accumulation, while a decrease may signal the liquidation of assets to fund operations.
Detailed definition
These are financial instruments held by the company that are intended to be held for longer than one year or are restric...
Peer comparison
Common in insurance and healthcare sectors where companies manage large investment portfolios to back long-term liabilities.
non_current_assets_short_term_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.01B | $3.02B | $3.12B | $2.9B | $2.88B | $2.79B | $2.78B | $3.1B | $3.08B | $3.15B | $3.26B | $3.29B | $3.76B | $2.81B | $2.41B | $2.58B | $2.39B | $2.13B | $2.15B | $2.26B |
| QoQ Change | — | +0.3% | +3.4% | -7.0% | -0.8% | -3.0% | -0.5% | +11.7% | -0.7% | +2.1% | +3.6% | +0.9% | +14.2% | -25.3% | -14.2% | +7.1% | -7.4% | -10.6% | +0.5% | +5.4% |
| YoY Change | — | — | — | — | -4.3% | -7.4% | -10.9% | +7.0% | +7.1% | +12.6% | +17.3% | +6.0% | +21.9% | -10.8% | -26.1% | -21.6% | -36.5% | -23.9% | -10.9% | -12.3% |
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) at Other Companies
Frequently Asked Questions
- What is CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
- CVS Health (CVS) reported short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) of $2.26B in Q1 2026.
- How has CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) changed year-over-year?
- CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) decreased by 12.3% year-over-year, from $2.58B to $2.26B.
- What is the long-term trend for CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
- Over 5 years (2020 to 2025), CVS Health's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) has grown at a -6.5% compound annual growth rate (CAGR), from $3B to $2.15B.
- What does short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) mean?
- Investments held by the company that are not intended to be converted to cash within the next year.